News

High performance protein biomarker profiles for Alzheimer’s Disease

An article from Professor Charlotte Teunissen's group in Amsterdam provides a striking example of how large-scale biomarker discovery ...

A protein biomarker risk score to predict overall 5-year survival in ovarian cancer

This study from Uppsala University details the large-scale clinical validation of a previously described 11-protein diagnostic protein profile ...

The proteomic signature of hepatic fibrosis in HIV-associated NAFLD

A team from Massachusetts General Hospital used the Olink® Target 96 CVD III and Immuno-oncology panels to identify circulating ...

Maria Martin-Grau, at the University of Valencia, Spain is selected for the 2022 Novelties in Biomarkers award

Press release: UPPSALA, Sweden, November 17, 2022 (GLOBE NEWSWIRE)

Olink® Explore 3072 found to be compatible with non-human primate plasma

We tested, and confirmed, that Olink® PEA technology is indeed compatible with non-human primate (NHP) plasma. By comparing results ...

Announcing Olink® Flex, a new, unique and fully flexible low-plex proteomics solution using absolute quantification

Press release: UPPSALA, Sweden, November 14, 2022 (GLOBE NEWSWIRE)

Celebrating 1000 Olink publications

1,000 peer-reviewed publication

Press release: UPPSALA, Sweden, November 3, 2022 (GLOBE NEWSWIRE)

Announcing Olink® Insight, a digital knowledge-sharing platform to amplify the value of proteomics data

Press release: UPPSALA, Sweden, October 24, 2022 (GLOBE NEWSWIRE)

Olink Population Health Summit 2022

A Pharma consortium of 13 companies and Olink technology recently enabled so far the world’s biggest proteomics study on ...